Hints and tips:
...“We’re just looking for accountability for this particular product,” Shirian added. “No one is looking to take guns away from people. It’s very reminiscent of tobacco litigation....
...The ruling activated a dormant article in the European treaty that could set a significant precedent for EU regulators’ ability to go after more so-called killer acquisitions — no matter where they’re located...
...“We’re going to see a splintering soon, and I want university leaders to take responsibility and lead the way,” she adds....
...“With B Corp [certification] you have B Lab, that’s out there marketing that brand,” says Kassoy. “There’s no one doing that for consumers with legal structures.”...
...Cephalon, which also sold a fast-acting fentanyl product Actiq and had previously employed Burlakoff, settled investigations into its marketing practices in 2008 for $425m....
...Law firm Alston & Bird has hired Alex Park as a partner in the firm’s corporate transactions and securities practice. Park will be based in Washington and joins from Womble Bond Dickinson....
...There are more than 1,000 lawsuits brought by states and local governments in the US alleging the drugmaker’s marketing practices ignited and then fuelled the opioid crisis, which claimed more than 42,000...
...“There seems to be a disconnect where more services, delivered faster and in a more convenient fashion, no longer adds up to higher prices in the minds of consumers, and it has spread to this industry as...
...But to Paul Meyer, a Los Angeles-based principal and testifying expert at the Securities Litigation and Consulting Group, the rapid growth of SBLs is bound to end in tears....
...“He’s a litigation magnet and there’s no relief because you’re president. The Supreme Court has held that.” The election campaign has already spurred a recalibration of the Trump brand....
...In the words of George Osborne, chancellor: “If you evade tax we’re coming after you.”...
...launched privatisation and price reforms, adopting market economics in practice, if not name....
...But if no future Lipitor will dominate Pfizer, some believe no drug in any pharmaceutical company will ever match its sales....
...Also check that there is no outstanding litigation against the company. This work is vital, valuable and not free....
International Edition